Pure Biologics
Pre-clinicalPure Biologics’ therapeutic portfolio includes new immunooncology therapies. In these innovative projects we use antibody technologies to develop molecules with therapeutic potential.
Founded
2013
Focus
AntibodiesBiologicsDiagnostics
About
Pure Biologics’ therapeutic portfolio includes new immunooncology therapies. In these innovative projects we use antibody technologies to develop molecules with therapeutic potential.
Funding History
2Total raised: $9.8M
Series A$8MUndisclosedJun 15, 2020
Seed$1.8MUndisclosedJun 15, 2017
Company Info
TypePrivate
Founded2013
LocationWroclaw, Poland
StagePre-clinical
Contact
SIMILAR COMPANIES
AILIS Breast Cancer
Pre-clinical · Warsaw
Biocam
Pre-clinical · Warsaw
Bioton
Pre-clinical · Warsaw
Ensera
Pre-clinical · Warsaw
Biovico
Pre-clinical · Warsaw
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile